Current research on respiratory viral infections: Third International Symposium

Identifieur interne : 001750 ( Istex/Corpus ); précédent : 001749; suivant : 001751

---

Current research on respiratory viral infections: Third International Symposium

Auteurs : Alexander C. Schmidt ; Robert B. Couch ; George J. Galasso ; Frederick G. Hayden ; John Mills ; Brian R. Murphy ; Robert M. Chanock

Source :

• Antiviral Research [ 0166-3542 ] ; 2001.

RBID : ISTEX:61A5CE0C570B86C6BC2ABD67ACE4300987FB4B9D

English descriptors

• Teeft :
  • Acad, Acute otitis media, Additional genes, Adenoviral, Adenovirus, Adenovirus attachment, Adenovirus infections, Adenovirus inhibitor, Adenovirus type, Adenovirus vaccines, Adult patients, Adult volunteers, Adverse effects, Agouron pharmaceuticals, Animal models, Animal virus, Anti6iral, Anti6iral research, Antibiotic, Antibody, Antibody preparations, Antibody response, Antibody therapy, Antigenic, Antigenic composition, Antigenic drift, Antigenic shift, Antigenic variation, Antiviral, Antiviral activity, Antiviral agents, Antiviral drugs, Antiviral effects, Antiviral therapy, Assay, Asthma, Asthmatic children, Attenuated, Attenuated virus vaccines, Attenuating, Attenuating mutations, Attenuation, Attenuation phenotype, Autoimmune diabetes, Avian, Avian species, Bacterial infection, Bacterial pneumonia, Basic training, Baylor college, Belshe, Breast cancer, Bronchoalveolar lavage, Candidate vaccine, Candidate vaccines, Case fatality rates, Causative agent, Cdna, Cell culture, Cell death, Cell membrane, Cell surface receptors, Cells transfected, Chanock, Chemical mutagenesis, Chimpanzee, Chimpanzee coryza agent, Chronic lung disease, Clin, Clinical disease, Clinical manifestations, Clinical studies, Clinical symptoms, Clinical trials, Common cause, Common complication, Comparison group, Confocal microscopy, Congenital heart disease, Control group, Core body temperature, Cotton rats, Crowe, Ctls, Curative medicine, Cynomologous monkeys, Cytokine, Cytoplasmic, Cytoplasmic domain, Cytoplasmic domains, Cytoplasmic inclusions, Cytotoxic lymphocytes, Deletion, Delta infants, Different levels, Different organ tropism, Dominant antibody isotype, Donor virus, Dose intranasally, Early region, Effective vaccine, Elderly patients, Engl, Englund, Environmental factors, Epidemic circumstances, Epidemiology, Epithelial cells, Etiologic agent, Excess mortality, Frederick hayden, Free virus, Fusion glycoprotein, Fusion inhibition, Fusion peptide, Gastrointestinal symptoms, Gastrointestinal tract, Gene, Gene deletion, Gene expression, Gene products, Genetic basis, Genetics, Genetics system, Genetics systems, Genome, Ghildyal, Glaxo wellcome, Glycoprotein, Glycoprotein genes, Healthy adults, Hematologic malignancies, Hexon characteristics, High dose groups, High dose treatment, High titer, Hong kong, Horwitz, Hospitalization, Host responses, Hpiv3, Human adenoviruses, Human rhinovirus, Human virus, Human virus type, Human viruses, Humanized, Illegitimate recombination, Immune, Immune responses, Immunocompromised, Immunocompromised adults, Immunocompromised children, Immunocompromised patients, Immunogenic, Immunogenicity, Important role, Infant, Infection, Infectious cycle, Infectious diseases, Infectious virus, Infectivity, Inhibitor, Internal genes, Intranasal, Intranasal administration, Intranasally, John mills, Johns hopkins university, Karron, Kinase, Longitudinal study, Lrti, Lung tissue, Maassab, Macfarlane burnet center, Macrae group, Mass casualties, Maternal antibodies, Measles virus, Mechanical ventilation, Medical risk factors, Microbiol, Military recruits, Military trainees, Military training camps, Monoclonal antibody, More immunogenic, Mouse, Mouse model, Much progress, Mucosal, Mutagenesis, Mutant, Mutant virus, Mutant viruses, Mutation, Mycophenolic acid, Nasal, Nasal secretions, Nasal wash, National institutes, Natl, Neisseria meningitidis, Neuraminidase, Neuraminidase inhibitor oseltamivir, Neuraminidase inhibitors, Neuraminidase treatment, Neutralizing, Neutralizing activity, Neutralizing antibodies, Neutralizing antibody, Next pandemic, Nucleocapsid proteins, Older antivirals, Older children, Oral oseltamivir, Oseltamivir, Oseltamivir group, Other factors, Other hand, Other paramyxoviruses, Otitis, Otitis media, Outbreak, Overall effect, Pandemic, Pandemic viruses, Paramyxovirus, Passive immunoprophylaxis, Pathogen, Pathogenesis, Peak expiratory, Peak titer, Pearl river, Pediatr, Pediatric, Pediatric investigators, Pediatric patients, Penton base protein, Peptide, Phenotype, Piv3, Placebo, Placebo group, Placebo recipients, Pleconaril, Pleconaril treatment, Pneumonia, Pneumoniae, Point mutations, Polymerase, Post infection, Potential pandemic viruses, Powerful tool, Pregnant women, Premature infants, Preterm infants, Primary endpoint, Primary infections, Primary mechanism, Primary mediator, Primate model, Proc, Process citation, Promising vaccine candidate, Prophylaxis, Prospective study, Protective immunity, Protein, Pulmonary disease, Pulmonary function, Rapid diagnosis, Re6erse genetics, Real time, Recent study, Recent years, Receptor, Receptor binding, Receptor blockade, Recombinant, Recombinant cdna technology, Relative risk, Replication, Resistant mutants, Resistant virus, Respiratory, Respiratory disease, Respiratory illness, Respiratory infections, Respiratory symptom score, Respiratory syncytial, Respiratory syncytial virus, Respiratory syncytial virus disease, Respiratory syncytial virus infection, Respiratory syncytial viruses, Respiratory tract, Respiratory tract disease, Respiratory tract illness, Respiratory tract infection, Respiratory tract infections, Respiratory virus infection, Respiratory virus infections, Respiratory viruses, Rhinovirus, Rhoa, Rhoa peptide, Robert chanock, Rodent models, Schmidt, Second dose, Second heptad, Secondary complications, Sendai virus, Sequence analysis, Seronegative, Seronegative infants, Serotypes, Serum antibody, Serum antibody response, Serum concentrations, Several reasons, Severe disease, Short regions, Sialic acid, Small gtpase, Streptococcus pneumoniae, Study group, Subgroup, Subunit, Subunit vaccine, Subunit vaccines, Sudden infant death, Surface glycoproteins, Symptom, Syncytial, Syncytial virus, Syncytium formation, Temperate climates, Temperature sensitivity, Timely manner, Tissue culture, Tissue tropism, Titer, Total days, Tract disease, Tract illness, Tract infection, Tract infections, Trainee, Training camps, Transplant rejection, Treatment group, Tropism, Tumor necrosis factor, Unexplained deaths, Vaccination, Vaccine, Vaccine candidate, Vaccine candidates, Vaccine development, Vaccine production, Vaccine production capability, Vaccine recipients, Vaccine strain, Vaccine virus, Vaccine viruses, Vero cells, Viral, Viral genome, Viral infection, Viral infections, Viral load, Viral polymerase, Viral vaccines, Virion assembly, Virol, Virology, Virulence factors, Virus, Virus disease, Virus infection, Virus infections, Virus isolation, Virus replication, Virus titers, Virus type, Virus vaccine, Virus vaccines, Weight loss, Wild type virus, Winter months, World monkeys, Young children, Young infants.

Url:

• https://api.istex.fr/ark:/67375/6H6-1R3J13KK-W/fulltext.pdf

DOI: 10.1016/S0166-3542(01)00136-X

---

Links to Exploration step

ISTEX:61A5CE0C570B86C6BC2ABD67ACE4300987FB4B9D

---

Le document en format XML

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001750 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 001750 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:61A5CE0C570B86C6BC2ABD67ACE4300987FB4B9D
   |texte=   Current research on respiratory viral infections: Third International Symposium
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021